Quadruple Immunotherapy for Neuroblastoma

Condition:   Neuroblastoma Recurrent Interventions:   Biological: Natural killer cell;   Drug: Dinutuximab beta;   Drug: Interleukin-2;   Drug: Granulocyte-Macrophage Colony-Stimulating Factor;   Drug: Spironolactone Sponsors:   Hong Kong Children's Hospital;   The University of Hong Kong Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials